APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance and Drug Safety Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmacovigilance and Drug Safety Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 April 2026193 pages

Choose your research edition.

Industry ResearchPharmacovigilance and Drug Safety Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance and Drug Safety Software Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance and Drug Safety Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance and Drug Safety Software Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance and Drug Safety Software Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pharmacovigilance and Drug Safety Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmacovigilance and Drug Safety Software include Oracle, Veeva Systems, ArisGlobal, IQVIA, EXTEDO, RxLogix, Ennov, Uppsala Monitoring Centre and Medidata, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmacovigilance and Drug Safety Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacovigilance and Drug Safety Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacovigilance and Drug Safety Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacovigilance and Drug Safety Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmacovigilance and Drug Safety Software Segment by Company

Oracle

Veeva Systems

ArisGlobal

IQVIA

EXTEDO

RxLogix

Ennov

Uppsala Monitoring Centre

Medidata

Clarivate

AB Cube

Cloudbyz

Cognizant Technology

Taimei Technology

eMedyun

Bioknow

Singedi Health

Pharmacovigilance and Drug Safety Software Segment by Type

Adverse Event Reporting Software

Drug Safety Audits Software

Issue Tracking Software

Fully Integrated Software

Pharmacovigilance and Drug Safety Software Segment by Application

Pharma and Biotech Companies

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

Pharmacovigilance Service Providers

Others

Pharmacovigilance and Drug Safety Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance and Drug Safety Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance and Drug Safety Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance and Drug Safety Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacovigilance and Drug Safety Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance and Drug Safety Software industry.

Chapter 3: Detailed analysis of Pharmacovigilance and Drug Safety Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance and Drug Safety Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Adverse Event Reporting Software Table 3. Key Players of Drug Safety Audits Software Table 4. Key Players of Issue Tracking Software Table 3. Key Players of Fully Integrated Software Table 4. Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharma and Biotech Companies Table 6. Key Players of Contract Research Organizations (CROs) Table 7. Key Players of Business Process Outsourcing (BPO) Firms Table 8. Key Players of Pharmacovigilance Service Providers Table 9. Key Players of Others Table 10. Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Pharmacovigilance and Drug Safety Software Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Pharmacovigilance and Drug Safety Software Market Share by Region (2021-2026) Table 13. Global Pharmacovigilance and Drug Safety Software Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Pharmacovigilance and Drug Safety Software Market Share by Region (2027-2032) Table 15. Pharmacovigilance and Drug Safety Software Industry Trends Table 16. Pharmacovigilance and Drug Safety Software Industry Drivers Table 17. Pharmacovigilance and Drug Safety Software Industry Opportunities and Challenges Table 18. Pharmacovigilance and Drug Safety Software Industry Restraints Table 19. Global Pharmacovigilance and Drug Safety Software Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Company (2021-2026) Table 21. Global Pharmacovigilance and Drug Safety Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmacovigilance and Drug Safety Software Key Company Head Office and Area Served Table 23. Global Pharmacovigilance and Drug Safety Software Company, Product Type & Application Table 24. Global Pharmacovigilance and Drug Safety Software Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmacovigilance and Drug Safety Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Pharmacovigilance and Drug Safety Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2021-2026) Table 31. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2027-2032) Table 32. Global Pharmacovigilance and Drug Safety Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Application (2021-2026) Table 36. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Application (2027-2032) Table 37. Oracle Company Information Table 38. Oracle Business Overview Table 39. Oracle Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Oracle Pharmacovigilance and Drug Safety Software Product Portfolio Table 41. Oracle Recent Development Table 42. Veeva Systems Company Information Table 43. Veeva Systems Business Overview Table 44. Veeva Systems Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Veeva Systems Pharmacovigilance and Drug Safety Software Product Portfolio Table 46. Veeva Systems Recent Development Table 47. ArisGlobal Company Information Table 48. ArisGlobal Business Overview Table 49. ArisGlobal Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. ArisGlobal Pharmacovigilance and Drug Safety Software Product Portfolio Table 51. ArisGlobal Recent Development Table 52. IQVIA Company Information Table 53. IQVIA Business Overview Table 54. IQVIA Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. IQVIA Pharmacovigilance and Drug Safety Software Product Portfolio Table 56. IQVIA Recent Development Table 57. EXTEDO Company Information Table 58. EXTEDO Business Overview Table 59. EXTEDO Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. EXTEDO Pharmacovigilance and Drug Safety Software Product Portfolio Table 61. EXTEDO Recent Development Table 62. RxLogix Company Information Table 63. RxLogix Business Overview Table 64. RxLogix Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. RxLogix Pharmacovigilance and Drug Safety Software Product Portfolio Table 66. RxLogix Recent Development Table 67. Ennov Company Information Table 68. Ennov Business Overview Table 69. Ennov Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Ennov Pharmacovigilance and Drug Safety Software Product Portfolio Table 71. Ennov Recent Development Table 72. Uppsala Monitoring Centre Company Information Table 73. Uppsala Monitoring Centre Business Overview Table 74. Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Product Portfolio Table 76. Uppsala Monitoring Centre Recent Development Table 77. Medidata Company Information Table 78. Medidata Business Overview Table 79. Medidata Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Medidata Pharmacovigilance and Drug Safety Software Product Portfolio Table 81. Medidata Recent Development Table 82. Clarivate Company Information Table 83. Clarivate Business Overview Table 84. Clarivate Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Clarivate Pharmacovigilance and Drug Safety Software Product Portfolio Table 86. Clarivate Recent Development Table 87. AB Cube Company Information Table 88. AB Cube Business Overview Table 89. AB Cube Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. AB Cube Pharmacovigilance and Drug Safety Software Product Portfolio Table 91. AB Cube Recent Development Table 92. Cloudbyz Company Information Table 93. Cloudbyz Business Overview Table 94. Cloudbyz Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Cloudbyz Pharmacovigilance and Drug Safety Software Product Portfolio Table 96. Cloudbyz Recent Development Table 97. Cognizant Technology Company Information Table 98. Cognizant Technology Business Overview Table 99. Cognizant Technology Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Cognizant Technology Pharmacovigilance and Drug Safety Software Product Portfolio Table 101. Cognizant Technology Recent Development Table 102. Taimei Technology Company Information Table 103. Taimei Technology Business Overview Table 104. Taimei Technology Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Taimei Technology Pharmacovigilance and Drug Safety Software Product Portfolio Table 106. Taimei Technology Recent Development Table 107. eMedyun Company Information Table 108. eMedyun Business Overview Table 109. eMedyun Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. eMedyun Pharmacovigilance and Drug Safety Software Product Portfolio Table 111. eMedyun Recent Development Table 112. Bioknow Company Information Table 113. Bioknow Business Overview Table 114. Bioknow Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Bioknow Pharmacovigilance and Drug Safety Software Product Portfolio Table 116. Bioknow Recent Development Table 117. Singedi Health Company Information Table 118. Singedi Health Business Overview Table 119. Singedi Health Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Singedi Health Pharmacovigilance and Drug Safety Software Product Portfolio Table 121. Singedi Health Recent Development Table 122. North America Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026) & (US$ Million) Table 123. North America Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032) & (US$ Million) Table 124. North America Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026) & (US$ Million) Table 125. North America Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032) & (US$ Million) Table 126. North America Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026) Table 128. North America Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032) Table 129. Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026) & (US$ Million) Table 130. Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032) & (US$ Million) Table 131. Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026) & (US$ Million) Table 132. Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032) & (US$ Million) Table 133. Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026) Table 135. Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032) Table 136. China Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026) & (US$ Million) Table 137. China Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032) & (US$ Million) Table 138. China Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026) & (US$ Million) Table 139. China Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032) & (US$ Million) Table 140. Asia Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026) & (US$ Million) Table 141. Asia Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032) & (US$ Million) Table 142. Asia Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026) & (US$ Million) Table 143. Asia Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026) Table 146. Asia Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032) Table 147. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026) & (US$ Million) Table 148. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032) & (US$ Million) Table 149. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026) Table 153. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Pharmacovigilance and Drug Safety Software Product Image Figure 2. Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmacovigilance and Drug Safety Software Market Share by Type: 2025 VS 2032 Figure 4. Adverse Event Reporting Software Image Figure 5. Drug Safety Audits Software Image Figure 6. Issue Tracking Software Image Figure 7. Fully Integrated Software Image Figure 8. Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmacovigilance and Drug Safety Software Market Share by Application: 2025 VS 2032 Figure 10. Pharma and Biotech Companies Image Figure 11. Contract Research Organizations (CROs) Image Figure 12. Business Process Outsourcing (BPO) Firms Image Figure 13. Pharmacovigilance Service Providers Image Figure 14. Others Image Figure 15. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 17. Global Pharmacovigilance and Drug Safety Software Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Pharmacovigilance and Drug Safety Software Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Pharmacovigilance and Drug Safety Software Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Pharmacovigilance and Drug Safety Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Type (2021-2032) Figure 24. Global Pharmacovigilance and Drug Safety Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 27. North America Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032) Figure 28. North America Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032) Figure 29. North America Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032) Figure 30. United States Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 31. Canada Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 34. Europe Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032) Figure 35. Europe Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032) Figure 36. Europe Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032) Figure 37. Germany Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 38. France Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 40. Italy Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 41. Russia Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 44. China Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032) Figure 45. China Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032) Figure 46. Asia Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 47. Asia Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032) Figure 48. Asia Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032) Figure 49. Asia Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032) Figure 50. Japan Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 54. India Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 55. Australia Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032) Figure 60. Brazil Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 65. UAE Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 67. Chile Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software
  • Fully Integrated Software
Applications
  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPO) Firms
  • Pharmacovigilance Service Providers
  • Others
Companies covered
  • Oracle
  • Veeva Systems
  • ArisGlobal
  • IQVIA
  • EXTEDO
  • RxLogix
  • Ennov
  • Uppsala Monitoring Centre
  • Medidata
  • Clarivate
  • AB Cube
  • Cloudbyz
  • Cognizant Technology
  • Taimei Technology
  • eMedyun
  • Bioknow
  • Singedi Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Adverse Event Reporting Software
  5. 1.2.3 Drug Safety Audits Software
  6. 1.2.4 Issue Tracking Software
  7. 1.2.5 Fully Integrated Software
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharma and Biotech Companies
  11. 1.3.3 Contract Research Organizations (CROs)
  12. 1.3.4 Business Process Outsourcing (BPO) Firms
  13. 1.3.5 Pharmacovigilance Service Providers
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Pharmacovigilance and Drug Safety Software Growth Trends by Region
  17. 1.5.1 Global Pharmacovigilance and Drug Safety Software Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Pharmacovigilance and Drug Safety Software Market Size by Region (2021-2026)
  19. 1.5.3 Pharmacovigilance and Drug Safety Software Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Pharmacovigilance and Drug Safety Software Market Dynamics
  1. 2.1 Pharmacovigilance and Drug Safety Software Industry Trends
  2. 2.2 Pharmacovigilance and Drug Safety Software Industry Drivers
  3. 2.3 Pharmacovigilance and Drug Safety Software Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance and Drug Safety Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmacovigilance and Drug Safety Software Revenue by Company (2021-2026)
  2. 3.2 Global Pharmacovigilance and Drug Safety Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmacovigilance and Drug Safety Software Key Company Head office and Area Served
  4. 3.4 Global Pharmacovigilance and Drug Safety Software Company, Product Type & Application
  5. 3.5 Global Pharmacovigilance and Drug Safety Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmacovigilance and Drug Safety Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmacovigilance and Drug Safety Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmacovigilance and Drug Safety Software Tier 1, Tier 2, and Tier 3
4 Pharmacovigilance and Drug Safety Software Market by Type
  1. 4.1 Global Pharmacovigilance and Drug Safety Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2032)
  3. 4.3 Global Pharmacovigilance and Drug Safety Software Market Size Share by Type (2021-2032)
5 Pharmacovigilance and Drug Safety Software Market by Application
  1. 5.1 Global Pharmacovigilance and Drug Safety Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2032)
  3. 5.3 Global Pharmacovigilance and Drug Safety Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Oracle
  2. 6.1.1 Oracle Company Information
  3. 6.1.2 Oracle Business Overview
  4. 6.1.3 Oracle Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Oracle Pharmacovigilance and Drug Safety Software Product Portfolio
  6. 6.1.5 Oracle Recent Developments
  7. 6.2 Veeva Systems
  8. 6.2.1 Veeva Systems Company Information
  9. 6.2.2 Veeva Systems Business Overview
  10. 6.2.3 Veeva Systems Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Veeva Systems Pharmacovigilance and Drug Safety Software Product Portfolio
  12. 6.2.5 Veeva Systems Recent Developments
  13. 6.3 ArisGlobal
  14. 6.3.1 ArisGlobal Company Information
  15. 6.3.2 ArisGlobal Business Overview
  16. 6.3.3 ArisGlobal Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ArisGlobal Pharmacovigilance and Drug Safety Software Product Portfolio
  18. 6.3.5 ArisGlobal Recent Developments
  19. 6.4 IQVIA
  20. 6.4.1 IQVIA Company Information
  21. 6.4.2 IQVIA Business Overview
  22. 6.4.3 IQVIA Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 IQVIA Pharmacovigilance and Drug Safety Software Product Portfolio
  24. 6.4.5 IQVIA Recent Developments
  25. 6.5 EXTEDO
  26. 6.5.1 EXTEDO Company Information
  27. 6.5.2 EXTEDO Business Overview
  28. 6.5.3 EXTEDO Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 EXTEDO Pharmacovigilance and Drug Safety Software Product Portfolio
  30. 6.5.5 EXTEDO Recent Developments
  31. 6.6 RxLogix
  32. 6.6.1 RxLogix Company Information
  33. 6.6.2 RxLogix Business Overview
  34. 6.6.3 RxLogix Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 RxLogix Pharmacovigilance and Drug Safety Software Product Portfolio
  36. 6.6.5 RxLogix Recent Developments
  37. 6.7 Ennov
  38. 6.7.1 Ennov Company Information
  39. 6.7.2 Ennov Business Overview
  40. 6.7.3 Ennov Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Ennov Pharmacovigilance and Drug Safety Software Product Portfolio
  42. 6.7.5 Ennov Recent Developments
  43. 6.8 Uppsala Monitoring Centre
  44. 6.8.1 Uppsala Monitoring Centre Company Information
  45. 6.8.2 Uppsala Monitoring Centre Business Overview
  46. 6.8.3 Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Product Portfolio
  48. 6.8.5 Uppsala Monitoring Centre Recent Developments
  49. 6.9 Medidata
  50. 6.9.1 Medidata Company Information
  51. 6.9.2 Medidata Business Overview
  52. 6.9.3 Medidata Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medidata Pharmacovigilance and Drug Safety Software Product Portfolio
  54. 6.9.5 Medidata Recent Developments
  55. 6.10 Clarivate
  56. 6.10.1 Clarivate Company Information
  57. 6.10.2 Clarivate Business Overview
  58. 6.10.3 Clarivate Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Clarivate Pharmacovigilance and Drug Safety Software Product Portfolio
  60. 6.10.5 Clarivate Recent Developments
  61. 6.11 AB Cube
  62. 6.11.1 AB Cube Company Information
  63. 6.11.2 AB Cube Business Overview
  64. 6.11.3 AB Cube Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 AB Cube Pharmacovigilance and Drug Safety Software Product Portfolio
  66. 6.11.5 AB Cube Recent Developments
  67. 6.12 Cloudbyz
  68. 6.12.1 Cloudbyz Company Information
  69. 6.12.2 Cloudbyz Business Overview
  70. 6.12.3 Cloudbyz Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Cloudbyz Pharmacovigilance and Drug Safety Software Product Portfolio
  72. 6.12.5 Cloudbyz Recent Developments
  73. 6.13 Cognizant Technology
  74. 6.13.1 Cognizant Technology Company Information
  75. 6.13.2 Cognizant Technology Business Overview
  76. 6.13.3 Cognizant Technology Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Cognizant Technology Pharmacovigilance and Drug Safety Software Product Portfolio
  78. 6.13.5 Cognizant Technology Recent Developments
  79. 6.14 Taimei Technology
  80. 6.14.1 Taimei Technology Company Information
  81. 6.14.2 Taimei Technology Business Overview
  82. 6.14.3 Taimei Technology Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Taimei Technology Pharmacovigilance and Drug Safety Software Product Portfolio
  84. 6.14.5 Taimei Technology Recent Developments
  85. 6.15 eMedyun
  86. 6.15.1 eMedyun Company Information
  87. 6.15.2 eMedyun Business Overview
  88. 6.15.3 eMedyun Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 eMedyun Pharmacovigilance and Drug Safety Software Product Portfolio
  90. 6.15.5 eMedyun Recent Developments
  91. 6.16 Bioknow
  92. 6.16.1 Bioknow Company Information
  93. 6.16.2 Bioknow Business Overview
  94. 6.16.3 Bioknow Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Bioknow Pharmacovigilance and Drug Safety Software Product Portfolio
  96. 6.16.5 Bioknow Recent Developments
  97. 6.17 Singedi Health
  98. 6.17.1 Singedi Health Company Information
  99. 6.17.2 Singedi Health Business Overview
  100. 6.17.3 Singedi Health Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Singedi Health Pharmacovigilance and Drug Safety Software Product Portfolio
  102. 6.17.5 Singedi Health Recent Developments
7 North America
  1. 7.1 North America Pharmacovigilance and Drug Safety Software Market Size (2021-2032)
  2. 7.2 North America Pharmacovigilance and Drug Safety Software Market Size by Type
  3. 7.2.1 North America Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032)
  6. 7.3 North America Pharmacovigilance and Drug Safety Software Market Size by Application
  7. 7.3.1 North America Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032)
  10. 7.4 North America Pharmacovigilance and Drug Safety Software Market Size by Country
  11. 7.4.1 North America Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmacovigilance and Drug Safety Software Market Size (2021-2032)
  2. 8.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Type
  3. 8.2.1 Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmacovigilance and Drug Safety Software Market Size by Application
  7. 8.3.1 Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmacovigilance and Drug Safety Software Market Size by Country
  11. 8.4.1 Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmacovigilance and Drug Safety Software Market Size (2021-2032)
  2. 9.2 China Pharmacovigilance and Drug Safety Software Market Size by Type
  3. 9.2.1 China Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032)
  6. 9.3 China Pharmacovigilance and Drug Safety Software Market Size by Application
  7. 9.3.1 China Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmacovigilance and Drug Safety Software Market Size (2021-2032)
  2. 10.2 Asia Pharmacovigilance and Drug Safety Software Market Size by Type
  3. 10.2.1 Asia Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmacovigilance and Drug Safety Software Market Size by Application
  7. 10.3.1 Asia Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmacovigilance and Drug Safety Software Market Size by Country
  11. 10.4.1 Asia Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmacovigilance and Drug Safety Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst